MCL1 and acute myeloid leukemia: While previous studies have successfully applied multi-tiered in silico methods to optimize anti-cancer scaffolds, our study is distinct in its focused application to Mcl-1 inhibition in the context of AML, leveraging a series of 1,2,4-triazolo[4,3-b]pyridazine derivatives.